Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
Deferiprone Not Beneficial for Newly Diagnosed Parkinson Disease
Use of New-to-Market Neurologic Medications Reported to Be Low
Dextromethorphan-Bupropion Delays Relapse of Alzheimer Disease Agitation
Gene Therapy Gets Priority Review for Duchenne Muscular Dystrophy
Guidance Provided for Identifying, Managing CP in Primary Care
Efgartigimod SC Formulation Gets Priority Review for Myasthenia Gravis
Cognitive Scores Lower for Children With Iron Deficiency
Sezaby Approved to Treat Seizures in Term and Preterm Infants
Serdexmethylphenidate Gets Orphan Drug Status for Idiopathic Hypersomnia
Gantenerumab Fails to Meet Endpoints in Early Alzheimer Disease Trials
FDA to Review Zilucoplan for Generalized Myasthenia Gravis
Novel Formulation of Carbidopa/Levodopa Under Review for Parkinson Disease
Antiepileptic Med Use Increasing in Nursing Home Residents With Dementia
Telmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients
ENT-01 Safe, Improves Constipation in Patients With Parkinson Disease
DaTscan Approved for Use in Patients With Suspected Lewy Body Dementia
October 2022 Recap: Drug Pipeline Updates
